Recently, according to a report by the British Broadcasting Corporation (BBC), a 12-year-old British girl named Sarah Griffin has been diagnosed with asthma. A month ago, she was admitted to the hospital due to respiratory issues, which led to her being in a coma for four days. It has also been revealed that she frequently uses e-cigarettes.
The UK government has announced plans to restrict the marketing and sales of e-cigarettes targeted at children. Prime Minister Rishi Sunak stated that these proposals will seek public opinion within the next eight weeks, with the aim of reducing the appeal of e-cigarettes to children by limiting their colors and attractiveness. This move is intended to reverse the alarming increase in the number of teenagers using e-cigarettes.
Health Minister Steve Barclay has stated that the government is committed to taking legislative action immediately following consultations. He told the British Broadcasting Corporation that both headteachers and parents are concerned about our children becoming targets of e-cigarette companies.
Shadow Health Secretary Wes Stringer, speaking at the Labour Party conference, stated that the party will take strong measures to crackdown on e-cigarette companies promoting flavors such as "Rainbow Burst" to children.
Four days later, Sarah is gradually recovering and currently undergoing rehabilitation, but her lungs have sustained permanent damage. Sarah hopes that her experience can help other individuals of her age recognize the dangers posed by e-cigarettes.
"Do not initiate this action, as once you start doing it, you will not cease," she cautioned.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
